REGN
Regeneron Pharmaceuticals Inc
Biotechnology
Regeneron Pharmaceuticals Inc (REGN) Financials
Annual revenue, profit, EPS and free cash flow for REGN, pulled directly from its SEC 10-K filings — 2 fiscal years on record.
| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (Diluted) | Free Cash Flow |
|---|---|---|---|---|---|---|
| FY2025 | $14.3B | — | $3.6B | — | $41.48 | — |
| FY2024 | $14.2B | — | $4.0B | — | $38.34 | — |
Figures as reported on SEC Form 10-K. Free cash flow is operating cash flow less capital expenditure.